RWM
EW icon

Rialto Wealth Management’s Edwards Lifesciences EW Stock Holding History

Rialto Wealth Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4K Buy
50
+22
+79% +$1.81K ﹤0.01% 640
2025
Q4 		$2.39K Buy
28
+1
+4% +$82 ﹤0.01% 685
2025
Q3 		$2.1K Buy
27
+4
+17% +$313 ﹤0.01% 651
2025
Q2 		$1.8K Buy
+23
New +$1.72K ﹤0.01% 642

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Rialto Wealth Management's EW Position: Q1 2026 in Review

Rialto Wealth Management increased its Edwards Lifesciences (EW) stake by 79% in Q1 2026, buying an estimated $1.81K and bringing the position to 50 shares worth $4K. The position accounts for ﹤0.01% of the portfolio, ranked #640.

Rialto Wealth Management first reported a position in EW in Q2 2025 and has held it in 4 quarters since. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Rialto Wealth Management held 50 shares of Edwards Lifesciences worth $4K as of Q1 2026.
  • Rialto Wealth Management bought 22 Edwards Lifesciences shares in Q1 2026, an estimated $1.81K.
  • Edwards Lifesciences made up ﹤0.01% of Rialto Wealth Management's portfolio in Q1 2026, its #640 holding.
  • Rialto Wealth Management first reported a position in Edwards Lifesciences in Q2 2025 and has held it in 4 quarters since.
  • 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Rialto Wealth Management's 13F filing for Q1 2026, filed 14 May 2026.